Literature DB >> 15606393

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario.

J K Marshall1, M Thabane, A X Garg, W Clark, J Meddings, S M Collins.   

Abstract

BACKGROUND: Post-infectious irritable bowel syndrome is a common clinical phenomenon of uncertain aetiology. AIM: To test the association between intestinal permeability and irritable bowel syndrome symptoms 2 years after a large waterborne outbreak of bacterial gastroenteritis.
METHODS: Consecutive adults with Rome I irritable bowel syndrome and controls without irritable bowel syndrome attending a community clinic were enrolled. Intestinal permeability was measured as the ratio of fractional urinary excretions of lactulose and mannitol, and compared among cases vs. controls and predictors of abnormal intestinal permeability were assessed.
RESULTS: A total of 218 subjects (132 irritable bowel syndrome cases and 86 non-irritable bowel syndrome controls) completed the study protocol. About 27 (12%) had been diagnosed with the irritable bowel syndrome before the outbreak and 115 (53%) had been ill during the outbreak. Lactulose-mannitol ratios were increased among cases vs. controls (Mann-Whitney mean rank 118.8 vs. 95.3, P = 0.007), and cases were more likely to have a ratio >0.020 (P = 0.007). Among cases, those with increased intestinal permeability were more likely to report increased stool frequency. Both irritable bowel syndrome symptoms and male gender, but not diarrhoeal illness during the outbreak, were significant predictors of abnormal permeability.
CONCLUSIONS: Irritable bowel syndrome symptoms are associated with a subtle increase in intestinal permeability irrespective of prior gastroenteritis. This may improve understanding of the aetiology of both sporadic and post-infectious irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606393     DOI: 10.1111/j.1365-2036.2004.02284.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  83 in total

1.  Management of the returning traveler with diarrhea.

Authors:  Philippe P H de Saussure
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

2.  Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study.

Authors:  A Y Del Valle-Pinero; A C Martino; T J Taylor; B L Majors; N S Patel; M M Heitkemper; W A Henderson
Journal:  Neurogastroenterol Motil       Date:  2011-09-23       Impact factor: 3.598

3.  Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.

Authors:  Archana S Rao; Michael Camilleri; Deborah J Eckert; Irene Busciglio; Duane D Burton; Michael Ryks; Banny S Wong; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

Review 4.  Alterations in intestinal permeability.

Authors:  M C Arrieta; L Bistritz; J B Meddings
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 5.  The brain-gut axis in abdominal pain syndromes.

Authors:  Emeran A Mayer; Kirsten Tillisch
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

6.  The irritable infection. Interview by Paul C Adams.

Authors:  John Marshall
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

Review 7.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

8.  Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.

Authors:  Arseima Y Del Valle-Pinero; Hendrick E Van Deventer; Nicolaas H Fourie; Angela C Martino; Nayan S Patel; Alan T Remaley; Wendy A Henderson
Journal:  Clin Chim Acta       Date:  2013-01-14       Impact factor: 3.786

9.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

10.  Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase.

Authors:  Jae Woong Lee; Jung Ho Park; Dong I L Park; Jung-Hwan Park; Hong Joo Kim; Yong Kyun Cho; Chong I L Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Dig Dis Sci       Date:  2010-01-20       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.